The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy

Autor: Hu, Hongtu, Li, Weiwei, Hao, Yiqun, Peng, Zhuan, Zou, Zhengping, Wei, Jiali, Zhou, Ying, Liang, Wei, Cao, Yun
Zdroj: In Cell Reports Medicine 20 August 2024 5(8)
Databáze: ScienceDirect